<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1087">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04437940</url>
  </required_header>
  <id_info>
    <org_study_id>Acibadem Maslak Ob&amp;Gyn</org_study_id>
    <nct_id>NCT04437940</nct_id>
  </id_info>
  <brief_title>Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test</brief_title>
  <official_title>Evaluation of Vaginal Fluid for Covid-19 Positivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acibadem University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acibadem University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to investigate whether the Covid-19 is found in the vaginal swab samples
      of female patients diagnosed with covid-19, to evaluate the presence of Covid-19 and the risk
      of transmission of Covid-19 by intercourse or vaginal delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vaginal Covid-19 will be tested by taking vaginal swabs from female patients whose clinical
      findings are compatible with Covid-19 in AcÄ±badem Maslak Hospital. In patients with positive
      vaginal Covid-19 test, vaginal Covid-19 will be re-evaluated for the assessment of viral
      clearance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal fluid Covid-19 PCR test result</measure>
    <time_frame>1 month</time_frame>
    <description>Vaginal fluid Covid-19 test positivity rate for patients whose nasofarengeal test is positive</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>becoming negative from positive</measure>
    <time_frame>2 month</time_frame>
    <description>The ratio of negative test results to previous positive results for vaginal fluid Covid-19 test</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>COVID</condition>
  <condition>Sars-CoV2</condition>
  <arm_group>
    <arm_group_label>Covid-19 positive women</arm_group_label>
    <description>Women with nasofarangeal Covid-19 PCR test is positive</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vaginal fluid Covid-19 PCR test</intervention_name>
    <description>Vaginal fluid samples are tested for Covid-19</description>
    <arm_group_label>Covid-19 positive women</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Vaginal fluid
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women who are older than18 years old, who are considered to be covid-19 clinically and
        radiologically positive or nasofarengeal Covid-19 PCR test is positive will be included.

        Patients previously treated for covid-19 will be excluded from the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women who are positive nasofarengeal Covid-19 PCR test result

          -  Women who are 18 years or older

          -  Women who had sexual intercourse before

        Exclusion Criteria:

          -  who had medical treatment for Covid-19
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women who are older than 18 years old Women who had sexual intercourse before</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ozguc Takmaz, MD,Assist.Prof</last_name>
    <phone>+905554006591</phone>
    <email>ozguctakmaz@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Acibadem Maslak Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34457</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ozguc Takmaz, Assist. Prof.</last_name>
      <phone>05554006591</phone>
      <email>ozguctakmaz@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Eren Kaya, MD</last_name>
      <phone>+905359799914</phone>
      <email>erenkaya@acibadem.com</email>
    </contact_backup>
    <investigator>
      <last_name>Burak Celik</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Cui P, Chen Z, Wang T, Dai J, Zhang J, Ding T, Jiang J, Liu J, Zhang C, Shan W, Wang S, Rong Y, Chang J, Miao X, Ma X, Wang S. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract. Am J Obstet Gynecol. 2020 Jul;223(1):131-134. doi: 10.1016/j.ajog.2020.04.038. Epub 2020 May 4.</citation>
    <PMID>32376320</PMID>
  </reference>
  <results_reference>
    <citation>Qiu L, Liu X, Xiao M, Xie J, Cao W, Liu Z, Morse A, Xie Y, Li T, Zhu L. SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection. Clin Infect Dis. 2020 Jul 28;71(15):813-817. doi: 10.1093/cid/ciaa375.</citation>
    <PMID>32241022</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 17, 2020</study_first_submitted>
  <study_first_submitted_qc>June 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2020</study_first_posted>
  <last_update_submitted>June 17, 2020</last_update_submitted>
  <last_update_submitted_qc>June 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Acibadem University</investigator_affiliation>
    <investigator_full_name>Ozguc Takmaz</investigator_full_name>
    <investigator_title>MD,Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data of the patients will be shared without personel informations</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

